FGFR3 Alteration
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma (NCT04919642) | TransThera Sciences (Nanjing), Inc. | 2021-12-07 |
Track FGFR3 Alteration automatically
Every clearance here is in the API, with alerts when new ones post.